NEXGEL, Inc. (NXGLW) stock
NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $34.21MP/E –Yield –
Nexgel operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Nexgel's operating cash flow for the twelve months ending Jun 30, 2026 was -$3.21M. For fiscal 2025 it was -$1.31M. The highest annual figure on record is -$1.31M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.31M | – |
| FY2024 | Dec 31, 2024 | -$3.87M | – |
| FY2023 | Dec 31, 2023 | -$3.24M | – |
| FY2022 | Dec 31, 2022 | -$2.99M | – |
| FY2021 | Dec 31, 2021 | -$2.75M | – |
| FY2020 | Dec 31, 2020 | -$1.80M | – |
| FY2019 | Dec 31, 2019 | -$1.81M | – |
| FY2018 | Dec 31, 2018 | -$1.54M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.20M | – |
| Q1 FY2026 | Mar 31, 2026 | -$504.00K | – |
| Q4 FY2025 | Dec 31, 2025 | $281.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$785.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$407.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$400.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$859.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.22M | – |
| Q2 FY2024 | Jun 30, 2024 | -$700.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.09M | – |
| Q4 FY2023 | Dec 31, 2023 | -$587.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$723.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.22M | – |
| Q1 FY2023 | Mar 31, 2023 | -$709.00K | – |
| Q4 FY2022 | Dec 31, 2022 | -$649.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$848.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$698.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$797.00K | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.20M | – |
| Q3 FY2021 | Sep 30, 2021 | -$523.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$688.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$345.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$423.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$398.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$320.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$660.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$387.00K | -244.9% |
| Q3 FY2019 | Sep 30, 2019 | -$268.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$603.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$556.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $267.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.06M | – |